Profile
Dr. Béatrice Llirbat is on the Board of Directors at Kadrige SA.
Dr. Llirbat was previously employed as Partner by Amundi Private Equity Funds SA, Partner by Société Générale Asset Mgmt Alternative Invt (Private Equity), Member-Supervisory Board by Génomic Vision SA, Member-Supervisory Board by Genticel SA, and Member-Supervisory Board by Trophos SA. He also served on the board at Intrasense SA, Adocia SA and Arterial Remodelling Technologies SA.
He received his doctorate degree from the University of Paris V and a doctorate degree from Université Pierre et Marie Curie.
Former positions of Béatrice Llirbat
| Companies | Position | End |
|---|---|---|
Amundi Private Equity Funds SA
 Amundi Private Equity Funds SA Investment ManagersFinance Amundi Private Equity Funds SA (Amundi PEF) is the private equity subsidiary of Amundi SA, itself a subsidiary of Crédit Agricole SA (XP: ACA) in France. Formerly known as CAAM-CI, founded in 1999 as CPR Private Equity, Amundi PEF was formed in 2009 by combining the Crédit Agricole and Société Générale asset management operations. The firm is headquartered in Paris and has additional offices in Bucharest, Cairo, Casablanca, Tunis and Warsaw. They invest in companies at all stages of development, providing institutional and individual investors with a wide spectrum of investment opportunities. | Private Equity Investor | 30/12/2012 |
Société Générale Asset Mgmt Alternative Invt (Private Equity)
 Société Générale Asset Mgmt Alternative Invt (Private Equity) Investment ManagersFinance Societé Générale Asset Management Alternative Investment/Private Equity (SGAM AI/PE) is the banking group's European asset management center for Private Equity. They are located in Paris-La Défense. SGAM AI/PE is a division of the Société Générale Asset Management, established in 2003, which is a subsidiary of the bank's Global Investment Management and Services division. The ultimate parent firm is the French financial institution Société Générale (PK: SCGLY), established in 1864. Nationalized at different intervals throughout their history, the bank is in the private sector since 1997. SGAM AI/PE is composed of three units: venture capital, expansion capital and buyout, and fund of funds. In addition to their Paris office, they are also present in London, Milan, Munich, Warsaw, Bucharest and Casablanca. | Private Equity Investor | 15/02/2010 |
Arterial Remodelling Technologies SA
 Arterial Remodelling Technologies SA Pharmaceuticals: MajorHealth Technology Arterial Remodelling Technologies SA develops bioresorbable peripheral and coronary polymer stents. Its products includes ART PBS scaffold, procedure and Clinical data. The company was founded by Antoine Lafont, Michel Vert and J. Frederick Cornhill in 2001 and is headquartered in Paris, France. | Director/Board Member | - |
Kadrige SA
 Kadrige SA Data Processing ServicesTechnology Services Kadrige SA provides information technology solutions. It offers technical integration, customization, consulting and support in your content production, integrating content and data, information, initial and ongoing training, coaching, delegation of staff, management, consulting. The company was founded by Olivier Cadou in 2002 and is headquartered in Boulogne-Billancourt, France. | Director/Board Member | - |
| GENOMIC VISION | Director/Board Member | - |
Training of Béatrice Llirbat
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 3 |
|---|---|
| GENOMIC VISION | Health Technology |
| INTRASENSE | Technology Services |
| ADOCIA | Health Technology |
| Private companies | 8 |
|---|---|
Trophos SA
 Trophos SA Pharmaceuticals: MajorHealth Technology Trophos SA engages in manufacturing and development of pharmaceutical products. It offers medicines to patients with conditions such as amyotrophic lateral sclerosis, spinal muscular atrophy and cardiac ischemia reperfusion injury. The company was founded by Antoine Beret and Michel Delaage in 1991 and is headquartered in Marseille, France. | Health Technology |
| Université Pierre et Marie Curie | Consumer Services |
Société Générale Asset Mgmt Alternative Invt (Private Equity)
Société Générale Asset Mgmt Alternative Invt (Private Equity) Investment ManagersFinance Societé Générale Asset Management Alternative Investment/Private Equity (SGAM AI/PE) is the banking group's European asset management center for Private Equity. They are located in Paris-La Défense. SGAM AI/PE is a division of the Société Générale Asset Management, established in 2003, which is a subsidiary of the bank's Global Investment Management and Services division. The ultimate parent firm is the French financial institution Société Générale (PK: SCGLY), established in 1864. Nationalized at different intervals throughout their history, the bank is in the private sector since 1997. SGAM AI/PE is composed of three units: venture capital, expansion capital and buyout, and fund of funds. In addition to their Paris office, they are also present in London, Milan, Munich, Warsaw, Bucharest and Casablanca. | Finance |
Arterial Remodelling Technologies SA
Arterial Remodelling Technologies SA Pharmaceuticals: MajorHealth Technology Arterial Remodelling Technologies SA develops bioresorbable peripheral and coronary polymer stents. Its products includes ART PBS scaffold, procedure and Clinical data. The company was founded by Antoine Lafont, Michel Vert and J. Frederick Cornhill in 2001 and is headquartered in Paris, France. | Health Technology |
Kadrige SA
Kadrige SA Data Processing ServicesTechnology Services Kadrige SA provides information technology solutions. It offers technical integration, customization, consulting and support in your content production, integrating content and data, information, initial and ongoing training, coaching, delegation of staff, management, consulting. The company was founded by Olivier Cadou in 2002 and is headquartered in Boulogne-Billancourt, France. | Technology Services |
Genticel SA
 Genticel SA BiotechnologyHealth Technology Genticel SA operates as a clinical stage biotechnology company, which focuses on the development of immunotherapies designed to fight infectious diseases and cancer. The company was founded by Bénédikt Timmerman and Ludovic de Meeus d'Argenteuil on October 15, 2001 and is headquartered in Labège, France. | Health Technology |
Amundi Private Equity Funds SA
Amundi Private Equity Funds SA Investment ManagersFinance Amundi Private Equity Funds SA (Amundi PEF) is the private equity subsidiary of Amundi SA, itself a subsidiary of Crédit Agricole SA (XP: ACA) in France. Formerly known as CAAM-CI, founded in 1999 as CPR Private Equity, Amundi PEF was formed in 2009 by combining the Crédit Agricole and Société Générale asset management operations. The firm is headquartered in Paris and has additional offices in Bucharest, Cairo, Casablanca, Tunis and Warsaw. They invest in companies at all stages of development, providing institutional and individual investors with a wide spectrum of investment opportunities. | Finance |
| Université de Paris 5 René Descartes | Consumer Services |
- Stock Market
- Insiders
- Béatrice Llirbat
